##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 12 (2024)

Self-reported perceptions of adults with diabetes regarding their care and health in the time of COVID-19 pandemic in a Swiss region: a cross-sectional study

Cite this as:
Swiss Med Wkly. 2024;154:3578
Published
05.12.2024

Summary

AIM: To assess the perceptions of adults with diabetes regarding their care and health during the COVID-19 pandemic in the canton of Vaud, Switzerland.

METHODS: Cross-sectional data was analysed from the 2021 follow-up questionnaire of the CoDiab-VD survey, a cohort of adults living with diabetes in the canton of Vaud. Various aspects of diabetes care and issues relating to the COVID-19 pandemic were assessed. Descriptive analyses were conducted to detail access to care, self-management, and psychosocial burden during the pandemic. Regression analyses were then performed to explore the relationship between these domains and factors associated with COVID-19 outcomes.

RESULTS: Respondents (n = 566; 79%) had a mean age of 70 years (range: 22–94), and most had type 2 diabetes (73%). The COVID-19 pandemic did not appear to have strongly affected their care. Indeed, access to diabetes care remained similar to before the pandemic: only 10% of respondents reported having diabetes-related care postponed or cancelled. While 16% experienced increased difficulty in managing physical activity, the majority were able to continue diabetes self-management, with minimal changes in glucose control. In terms of psychosocial burden, only 33% expressed high levels of worry about the pandemic.

CONCLUSION: Diabetes self-management, glucose control, and access to diabetes care were not severely affected for the CoDiab-VD cohort during the COVID-19 pandemic. Despite some reported postponements in care and increased difficulty in physical activity management, the majority maintained their diabetes management practices with minimal impact on glucose control. Overall, psychosocial worry about the pandemic was relatively low, highlighting the resilience of individuals in managing their diabetes despite challenging circumstances.

ClinicalTrials.gov number: NCT01902043

References

  1. Chew HS, Lopez V. Global Impact of COVID-19 on Weight and Weight-Related Behaviors in the Adult Population: A Scoping Review. Int J Environ Res Public Health. 2021 Feb;18(4):1876. doi: https://doi.org/10.3390/ijerph18041876
  2. Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020;14(5):917–20. doi: https://doi.org/10.1016/j.dsx.2020.05.044
  3. Blustein DL, Duffy R, Ferreira JA, Cohen-Scali V, Cinamon RG, Allan BA. Unemployment in the time of COVID-19: A research agenda. J Vocat Behav. 2020 Jun;119:103436. doi: https://doi.org/10.1016/j.jvb.2020.103436
  4. Prati G. Mental health and its psychosocial predictors during national quarantine in Italy against the coronavirus disease 2019 (COVID-19). Anxiety Stress Coping. 2021 Mar;34(2):145–56. doi: https://doi.org/10.1080/10615806.2020.1861253
  5. Serafini G, Parmigiani B, Amerio A, Aguglia A, Sher L, Amore M. The psychological impact of COVID-19 on the mental health in the general population. QJM. 2020 Jun;113(8):531–7. doi: https://doi.org/10.1093/qjmed/hcaa201
  6. Karatas S, Yesim T, Beysel S. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Prim Care Diabetes. 2021 Jun;15(3):424–7. doi: https://doi.org/10.1016/j.pcd.2021.01.003
  7. Zeigler Z. COVID-19 Self-quarantine and Weight Gain Risk Factors in Adults. Curr Obes Rep. 2021 Sep;10(3):423–33. doi: https://doi.org/10.1007/s13679-021-00449-7
  8. Daniel MM, Liboredo JC, Anastácio LR, Souza TC, Oliveira LA, Della Lucia CM, et al. Incidence and Associated Factors of Weight Gain During the Covid-19 Pandemic. Front Nutr. 2022 Feb;9:818632. doi: https://doi.org/10.3389/fnut.2022.818632
  9. Rudolph T, Eggenschwiler M, Kralle NC. Food Consumption 2021 - Ess- und Verzehrverhalten in Deutschland, Österreich und der Schweiz. St. Gallen, Switzerland: Forschungszentrum für Handelsmanagement; 2021.
  10. Ratzki-Leewing AA, Ryan BL, Buchenberger JD, Dickens JW, Black JE, Harris SB. COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study). BMJ Open. 2021 Sep;11(9):e049782. doi: https://doi.org/10.1136/bmjopen-2021-049782
  11. Binhardi BA, de Souza Teixeira CR, de Almeida-Pititto B, Barbosa-Junior F, Franco LJ, de Melo KF, et al. Diabetes self-care practices and resilience in the Brazilian COVID-19 pandemic: results of a web survey: DIABETESvid. Diabetol Metab Syndr. 2021 Aug;13(1):87. doi: https://doi.org/10.1186/s13098-021-00706-8
  12. Tejera-Perez C, Moreno-Pérez Ó, Rios J, Reyes-García R. People living with type 1 diabetes point of view in COVID-19 times (COVIDT1 study): disease impact, health system pitfalls and lessons for the future. Diabetes Res Clin Pract. 2021 Jan;171:108547. doi: https://doi.org/10.1016/j.diabres.2020.108547
  13. Yeoh E, Tan SG, Lee YS, Tan HH, Low YY, Lim SC, et al. Impact of COVID-19 and partial lockdown on access to care, self-management and psychological well-being among people with diabetes: A cross-sectional study. Int J Clin Pract. 2021 Aug;75(8):e14319. doi: https://doi.org/10.1111/ijcp.14319
  14. Shi Z, Yan A, Zimmet P, Sun X, Cristina do Vale Moreira N, Cheskin LJ, et al. COVID-19, Diabetes, and Associated Health Outcomes in China: Results from a Nationwide Survey of 10 545 Adults. Horm Metab Res. 2021 May;53(5):301–10. doi: https://doi.org/10.1055/a-1468-4535
  15. Sacre JW, Holmes-Truscott E, Salim A, Anstey KJ, Drummond GR, Huxley RR, et al. Impact of the COVID-19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: findings from the PREDICT cohort study. Diabet Med. 2021 Sep;38(9):e14611. doi: https://doi.org/10.1111/dme.14611
  16. Ruissen MM, Regeer H, Landstra CP, Schroijen M, Jazet I, Nijhoff MF, et al. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e002035. doi: https://doi.org/10.1136/bmjdrc-2020-002035
  17. Patel MR, Zhang G, Leung C, Song PX, Heisler M, Choe HM, et al. Impacts of the COVID-19 pandemic on unmet social needs, self-care, and outcomes among people with diabetes and poor glycemic control. Prim Care Diabetes. 2022 Feb;16(1):57–64. doi: https://doi.org/10.1016/j.pcd.2021.10.004
  18. Di Gangi S, Lüthi B, Diaz Hernandez L, Zeller A, Zechmann S, Fischer R. Quality outcome of diabetes care during COVID-19 pandemic: a primary care cohort study. Acta Diabetol. 2022 Sep;59(9):1189–200. doi: https://doi.org/10.1007/s00592-022-01920-0
  19. Zechmann S, Hotz L, Di Gangi S, Baumgartl K, Plate A, Potlukova E. Impact of SARS-CoV-2 Lockdown on Glycaemic Control: A Retrospective Observational Cohort Study in a Tertiary Setting. J Clin Med. 2021 Sep;10(18):4098. doi: https://doi.org/10.3390/jcm10184098
  20. Grabia M, Markiewicz-Żukowska R, Puścion-Jakubik A, Bielecka J, Nowakowski P, Gromkowska-Kępka K, et al. The Nutritional and Health Effects of the COVID-19 Pandemic on Patients with Diabetes Mellitus. Nutrients. 2020 Sep;12(10):3013. doi: https://doi.org/10.3390/nu12103013
  21. Maggio AB, Gal-Dudding C, Martin X, Chamay-Weber C. Evaluation of the impact of the COVID-19 lockdown on BMI in children and adolescents with or without obesity. BMC Pediatr. 2022 Aug;22(1):509. doi: https://doi.org/10.1186/s12887-022-03565-y
  22. Peytremann-Bridevaux I, Zuercher E, Carron T. CoDiab-VD: Cohort of Patients with Diabetes in the Canton of Vaud (Switzerland). Version 1.0 ed. Lausanne, Switzerland: Center for Primary Care and Public Health (Unisanté), University of Lausanne; 2019. doi: 10.16909/dataset/18
  23. Antille-Zuercher E, Carron T, Peytremann-Bridevaux I. Cohorte CoDiab-VD : Caractéristiques des patient·e·s diabétiques vaudois·es et évaluation de leur prise en charge : Etat des lieux en 2017 et comparaison avec 2011-2012. Raisons de santé. Lausanne: Institut universitaire de médecine sociale et préventive (IUMSP); 2019. doi: 10.16908/issn.1660-7104/293
  24. Zuercher E, Bordet J, Burnand B, Peytremann-Bridevaux I. CoDiab-VD: protocol of a prospective population-based cohort study on diabetes care in Switzerland. BMC Health Serv Res. 2015 Aug;15(1):329. doi: https://doi.org/10.1186/s12913-015-0991-0
  25. Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philos Trans A Math Phys Eng Sci. 2016 Apr;374(2065):20150202. doi: https://doi.org/10.1098/rsta.2015.0202
  26. Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011 Jun;2:53–5. doi: https://doi.org/10.5116/ijme.4dfb.8dfd
  27. Pallant J. SPSS Survival Manual: A Step by Step Guide to Data Analysis Using IBM SPSS. 7th ed. London: McGraw-Hill Education; 2020. 10.4324/9781003117452
  28. Yamashita T, Yamashita K, Kamimura R. A Stepwise AIC Method for Variable Selection in Linear Regression. Commun Stat Theory Methods. 2007;36(13):2395–403. doi: https://doi.org/10.1080/03610920701215639
  29. StataCorp. Stata Statistical Software: Release 17. College Station (TX): StataCorp LLC; 2021.
  30. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021.
  31. Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021 Feb;37(2):e3377. doi: https://doi.org/10.1002/dmrr.3377
  32. Ghosh-Swaby OR, Goodman SG, Leiter LA, Cheng A, Connelly KA, Fitchett D, et al. Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2020 May;8(5):418–35. doi: https://doi.org/10.1016/S2213-8587(20)30038-3
  33. Biamonte E, Pegoraro F, Carrone F, Facchi I, Favacchio G, Lania AG, et al. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect. Endocrine. 2021 Jun;72(3):604–10. doi: https://doi.org/10.1007/s12020-021-02739-5
  34. Naous E, Boulos M, Sleilaty G, Achkar AA, Gannagé-Yared MH. Quality of life and other patient-reported outcomes in adult Lebanese patients with type 2 diabetes during COVID-19 pandemic. J Endocrinol Invest. 2022 Apr;45(4):763–72. doi: https://doi.org/10.1007/s40618-021-01701-6
  35. Coulter A, Paparella G, McCulloch A. Listening to people: measuring views, experiences and perceptions. In: Anell A, Nolte E, Merkur S, editors. Achieving Person-Centred Health Systems: Evidence, Strategies and Challenges. European Observatory on Health Systems and Policies. Cambridge: Cambridge University Press; 2020. pp. 173–200. doi: https://doi.org/10.1017/9781108855464.010
  36. Bodenmann P, Favrat B, Wolff H, Guessous I, Panese F, Herzig L, et al. Screening primary-care patients forgoing health care for economic reasons. PLoS One. 2014 Apr;9(4):e94006. doi: https://doi.org/10.1371/journal.pone.0094006
  37. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar;34(3):220–33. doi: https://doi.org/10.1097/00005650-199603000-00003
  38. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994 Dec;272(22):1749–56. doi: https://doi.org/10.1001/jama.1994.03520220043029
  39. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May;166(10):1092–7. doi: https://doi.org/10.1001/archinte.166.10.1092
  40. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998 Sep;158(16):1789–95. doi: https://doi.org/10.1001/archinte.158.16.1789
  41. Swiss Federal Statistical Office. Swiss Health Survey. Available from: https://www.bfs.admin.ch/bfs/fr/home/statistiques/sante/enquetes/sgb.html#1002476496
  42. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999;8(1-2):79–91. doi: https://doi.org/10.1023/A:1026485130100